Factors influencing outcome of prednisone dose reduction in myasthenia gravis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 2046940.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We reviewed retrospectively 114 prednisone dose reduction attempts in 63 myasthenic patients. Dose reduction was considered successful if a patient remained asymptomatic for more than 1 year on no prednisone or a stable low dose of prednisone. Successful dose reduction attempts were more common in patients taking azathioprine, but thymectomy did not influence taper outcome. Slower rate of dose reduction and higher ending dose of prednisone improved the chance of success.
Medical subject headings
- Myasthenia Gravis
- Prednisone